Research location
Villefranche
France
Advertisement
Research activity in Villefranche
FranceCureCurrent currently publishes aggregate city-level research activity for this location: 15 trials and 15 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Villefranche
15 linked trials · page 1 of 1A Study Evaluating Platinum-Pemetrexed-Atezolizumab (+/-Bevacizumab) for Patients With Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer With EGFR Mutations, ALK Rearrangement or ROS1 Fusion Progressing After Targeted TherapiesNCT04042558 · 2019-09-26 · 1 site observation
COMPLETED
Double Immune Checkpoint Inhibitors in PD-L1-positive Stage IV Non-small Lung CancErNCT03469960 · 2018-05-02 · 1 site observation
COMPLETED
Combination of Cetuximab With Afatinib for Patient With EGFR Mutated Lung CancerNCT02716311 · 2016-05-01 · 1 site observation
COMPLETED
Nintedanib (Vargatef®) Plus Docetaxel in Second Line of Treatment in Patients With Lung CancerNCT02531737 · 2015-09-01 · 1 site observation
COMPLETED
Study of the Efficacy of SBRT on Unresectable Peripheral Primary TumorNCT02400424 · 2015-02-01 · 1 site observation
TERMINATED
A Multicenter Randomized Phase III Study Comparing Second-line Treatment With Chemotherapy Associated or Not to Erlotinib in NSCLC Patients With Secondary Resistance to TKI-EGFRNCT02178397 · 2014-06-01 · 1 site observation
TERMINATED
Description of Clinical Anatomical Features and Long Term Follow-up for Patients With ALK RearrangementsNCT02727335 · 2014-05-01 · 1 site observation
COMPLETED
Maintenance After Induction Chemotherapy in Elderly Patients With Advanced Non-small Cell Lung CancerNCT01850303 · 2013-05-16 · 1 site observation
COMPLETED
Paclitaxel-bevacizumab in Advanced Lung CancerNCT01763671 · 2013-05-01 · 1 site observation
COMPLETED
Strategies for Maintenance Therapies in Advanced Non Small Cell Lung CancerNCT01631136 · 2012-07-01 · 1 site observation
COMPLETED
Lung Cancer in Women Treated With Anti-oestrogens anD Inhibitors of EGFRNCT01556191 · 2012-05-15 · 1 site observation
COMPLETED
French Biological Observatory on Lung Cancer in Never SmokersNCT01465854 · 2011-11-01 · 1 site observation
COMPLETED
Erlotinib and Docetaxel in Second Line of Treatment in Patients With Non Small Cell Lung CancerNCT01350817 · 2011-06-01 · 1 site observation
COMPLETED
European Non-interventional Study in Chronic Obstructive Pulmonary Disease (COPD) PatientsNCT00722267 · 2008-07-01 · 1 site observation
COMPLETED
Study of an Early Change of a Chemotherapeutic Doublet Versus Four Cycles of Chemotherapy in Advanced Non Small Cell Lung CancerNCT00199758 · 2003-09-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.